Transcriptomics

Dataset Information

0

Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma [RNAseq_LHCN_hg19]


ABSTRACT: Chimeric transcription factors drive lineage-specific oncogenesis but are notoriously difficult to target. Alveolar rhabdomyosarcoma (RMS) is an aggressive childhood soft tissue sarcoma transformed by the pathognomonic PAX3–FOXO1 fusion protein, which governs a core regulatory circuitry transcription factor (CRC TF) network. Here we show that the histone lysine demethylase KDM4B is a therapeutic vulnerability for PAX3–FOXO1+ RMS. Genetic and pharmacologic inhibition of KDM4B significantly delays tumor growth by disrupting the expression of CRC TFs caused by epigenetic alterations of PAX3–FOXO1-governed super enhancers. Combining KDM4B inhibition with cytotoxic chemotherapy leads to significant tumor regression in preclinical PAX3–FOXO1+ RMS models. In summary, we have identified a targetable mechanism required for maintenance of PAX3-FOXO1-related CRC TF network, which may translate to a novel therapeutic approach for fusion-positive RMS.

ORGANISM(S): Homo sapiens

PROVIDER: GSE201224 | GEO | 2022/09/06

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-09-06 | GSE198755 | GEO
2022-09-06 | GSE198754 | GEO
2022-09-06 | GSE198752 | GEO
2022-09-06 | GSE198753 | GEO
2022-09-06 | GSE157094 | GEO
2022-09-06 | GSE157093 | GEO
2022-09-06 | GSE157092 | GEO
2023-09-12 | GSE242690 | GEO
2024-10-25 | GSE279336 | GEO
2024-10-25 | GSE279335 | GEO